DOPAMINE D2 AND D3 RECEPTOR OCCUPANCY OF CARIPRAZINE IN SCHIZOPHRENIC PATIENTS

被引：0
|
作者：
Keator, David B. [1 ]
Mukherjee, J. [1 ]
Preda, A. [1 ]
Highum, D. [1 ]
Lakatos, A. [1 ]
Gage, A. [2 ]
Potkin, S. G. [1 ]
机构：
[1] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA
[2] Forest Res Inst, Jersey City, NJ USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [11] Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
    Girgis, Ragy R.
    Slifstein, Mark
    D'Souza, Deepak
    Lee, Yih
    Periclou, Antonia
    Ghahramani, Parviz
    Laszlovszky, Istvan
    Durgam, Suresh
    Adham, Nika
    Nabulsi, Nabeel
    Huang, Yiyun
    Carson, Richard E.
    Kiss, Bela
    Kapas, Margit
    Abi-Dargham, Anissa
    Rakhit, Ashok
    [J]. PSYCHOPHARMACOLOGY, 2016, 233 (19-20) : 3503 - 3512
  • [12] Dopamine D2 and D3 receptor gene polymorphisms and clinical outcome of risperidone therapy in schizophrenic patients
    Gunes, A
    Scordo, MG
    Spina, E
    Dahl, ML
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S24 - S24
  • [13] Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
    Ragy R. Girgis
    Mark Slifstein
    Deepak D’Souza
    Yih Lee
    Antonia Periclou
    Parviz Ghahramani
    István Laszlovszky
    Suresh Durgam
    Nika Adham
    Nabeel Nabulsi
    Yiyun Huang
    Richard E. Carson
    Béla Kiss
    Margit Kapás
    Anissa Abi-Dargham
    Ashok Rakhit
    [J]. Psychopharmacology, 2016, 233 : 3503 - 3512
  • [14] Dopamine D2/D3 receptor availability and venturesomeness
    Bernow, Nina
    Yakushev, Igor
    Landvogt, Christian
    Buchholz, Hans-Georg
    Smolka, Michael N.
    Bartenstein, Peter
    Lieb, Klaus
    Gruender, Gerhard
    Vernaleken, Ingo
    Schreckenberger, Mathias
    Fehr, Christoph
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 2011, 193 (02) : 80 - 84
  • [15] On dopamine D2 and D3 receptor pharmacology - Ekman,A
    不详
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 1996, 50 (06) : 499 - 500
  • [16] AT ANTIPSYCHOTIC-LIKE EFFECTIVE DOSES, CARIPRAZINE DISPLAYS POTENT DOPAMINE D3 AND D2 RECEPTOR OCCUPANCY IN VIVO AND EFFICACY ACROSS ANIMAL MODELS
    Adham, N.
    Gyertyn, I.
    Laszlovszky, I.
    Kiss, B.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29
  • [17] Homozygosity at the dopamine D3 receptor gene in schizophrenic patients
    Durany, N
    Thome, J
    Palomo, A
    Foley, P
    Riederer, P
    CruzSanchez, FF
    [J]. NEUROSCIENCE LETTERS, 1996, 220 (03) : 151 - 154
  • [18] Bifeprunox:: Dopamine D2 receptor occupancy
    Devries, M
    Grahnen, A
    Bergström, M
    Långström, B
    Olsen, CK
    Brennum, LT
    Kreilgaard, M
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 243S - 244S
  • [19] Hyperprolactinemia is uncoupled from D2/D3 dopamine receptor occupancy in long-term amisulpride treated patients
    Bressan, RA
    Erlandsson, K
    Flanagan, RJ
    Ell, PJ
    Pilowsky, LS
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 239 - 239
  • [20] Effects of dopamine D3/D2 receptor agonists on body temperature and locomotion in dopamine D3 or D2 receptor knock-out mice
    Boulay, D
    Depoortere, R
    Perrault, G
    Sanger, DJ
    [J]. BRAIN RESEARCH, 1998, 809 (01) : A25 - A25
12345